BCAC Brookline Capital Acquisition Corp.

Bison Capital Acquisition Corp. does not have significant operations. It intends to acquire businesses or entities through share exchange, share reconstruction, amalgamation, assets purchase, and any other similar business combination. The company was founded in 2016 and is based in Beijing, China.

On 3/18/2022 the company announced a proposed merger with Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology.  

$22.71  +12.63 (125.30%)
As of 07/29/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  07/18/2017
Outstanding shares:  6,746,092
Average volume:  183,635
Market cap:   $153,203,749
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%